RecruitingPhase 3NCT04088396

A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA)

Studying Juvenile idiopathic arthritis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Eli Lilly and Company
Principal Investigator: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Eli Lilly and Company
Intervention: Baricitinib(drug)
Enrollment: 58 enrolled
Eligibility: 1-17 years · All sexes
Timeline: 2020 – 2026

Study locations (30)

Instituto CAICI SRL, Rosario, Argentina
Centro Medico Privado de Reumatologia, SAN M. de Tucuman, Argentina
UZ Gent, Ghent, Belgium
Faculdade de Medicina da UNESP, Botucatu, Brazil
Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil
IPITEC, São Paulo, Brazil
Universidade Federal de Sao Paulo, São Paulo, Brazil
Instituto da Crianca do Hospital das Clinicas da FMUSP, São Paulo, Brazil
Detska nemocnice FN Brno, Brno, Czechia
Vseobecna fakultni nemocnice v Praze, Prague, Czechia
Hospices Civils de Lyon - Hôpital Femme Mère Enfant, Bron, France
Hôpitaux Universitaires Paris Sud - Hôpital Bicêtre, Le Kremlin-Bicêtre, France
Centre Hospitalier Universitaire de Nîmes - Hôpital Universitaire Carémeau, Nîmes, France
Hôpital Universitaire Necker Enfants Malades, Paris, France
Centre Hospitalier Universitaire de Poitiers, Poitiers, France
+15 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04088396 on ClinicalTrials.gov

Other trials for Juvenile idiopathic arthritis

Additional recruiting or active studies for the same condition.

See all trials for Juvenile idiopathic arthritis →

← Back to all trials